Axio Research. LLC: Clinical Trials

3 trials sponsored by Axio Research. LLC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1
Phase 31Terminated 1

Follow Axio Research. LLC: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Two Tetanus-Diphtheria Vaccines for a Donor Hyper Immunization Program
Tetanus and Diphtheria (Td) Vaccine - Healthy
Phase 1CompletedBiomat USA, Inc.3002016-08-222021-07-20
Safety and Efficacy Study of EPI-743 in Children With Leigh Syndrome
Placebo, EPI-743 15 mg/kg, EPI-743 5 mg/kg - Leigh Syndrome
Phase 2CompletedPTC Therapeutics352012-10-312020-08-31
Niacin Plus Statin to Prevent Vascular Events
Extended release niacin, Simvastatin - Cardiovascular Diseases, Heart Diseases
Phase 3TerminatedAxio Research. LLC34142005-09-012016-04-06

Conditions studied

Atherosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Coronary Disease (1)  ·  Heart Diseases (1)  ·  Leigh Disease (1)  ·  Mitochondrial Diseases (1)  ·  Myocardial Infarction (1)  ·  Stroke (1)  ·  Tetanus (1)

Interventions

Niacin (1)  ·  Simvastatin (1)  ·  Tetanus Toxoid (1)  ·  Vaccines (1)  ·  alpha-tocotrienol quinone (1)

Countries

United States (3)  ·  Canada (1)

Top investigators

Jeffrey Probstfield, MD (1)  ·  Marilyn Rosa-Bray, MD (1)  ·  Ruth McBride (1)  ·  William E. Boden, MD (1)

Results publications

PMID 22085343, PMID 23881958, PMID 23916935, PMID 23973688, PMID 26708287, PMID 29627296, PMID 30371334, PMID 34134520

NIH funding

U01HL081616 (1), U01HL081649 (1)